News

News 04.12.2024 BALTIMORE--(BUSINESS WIRE)--Sapio Sciences, the science-aware™ lab informatics platform, today announced that evitria, a leader in antibody expression services, has selected Sapio’s Electronic Lab Notebook (ELN) and Sapio Report Builder to enhance its sample tracking, data capture, and reporting capabilities. Zurich-based evitria has established itself as a premier CHO-based transient expression services provider for...

News 27.11.2024 Franziska Riesen Fuchs joins as Head Operational Readiness. Dr. Franziska Riesen Fuchs has over 20 years of experience in the pharma and CDMO industry. Prior to joining DINAMIQS, she held different strategic and operational functions at Lonza and Roche, including QA, manufacturing and external manufacturing positions. In addition, she has experience...

News 19.11.2024 Schlieren (Zurich), Switzerland, November 19, 2024 – Kuros Biosciences (“Kuros”), a global leader in advanced bone healing technologies, today announced its strategic expansion into the extremities markets with the appointment of Jantzen Cole as Vice President of Market Development, Extremities, as well as the formation of a dedicated Surgeon Advisory...

News 18.11.2024 November 18, 2024 - Zurich, Switzerland InSphero, the global leader in scalable and reliable 3D in vitro cell culture solutions for drug discovery, takes a leading role in the recently awarded Chips JU European UNLOOC Project to advance its technology platform and address diversity in drug efficacy and safety testing. Launched in...

News 15.11.2024 Saint Herblain (France) and Schlieren (Zurich), November 13, 2024 – Valneva SE(Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and LimmaTech Biologics AG, a clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases, announced today that the first participant has been vaccinated in a Phase 2b controlled...